Fulcrum Metals (AIM:FMET) has completed a second amendment to its purchase option agreement with Terra Balcanica Resources and Terra North Resources over its Saskatchewan uranium portfolio.
The AIM-listed company, which develops cyanide-free technology to recover metals from mine waste, will receive 5.6m Terra North common shares at a deemed price of C$0.10 each within five business days, satisfying C$560,000 of the option's second-anniversary consideration.
That comes on top of C$75,000 in cash and 5.8m Terra Balcanica shares Fulcrum has already received under the option, which grants Terra North the right to acquire 100% of Fulcrum's Charlot-Neely, Fontaine Lake, Snowbird and South Pendleton uranium licences, covering roughly 591 square kilometres in northern Saskatchewan.
A separate C$75,000 cash payment due on the second anniversary has been deferred to the earlier of a new anniversary date following a Terra North going-public transaction or 31 October.
Fulcrum retains further potential consideration of C$225,000 in cash and C$1.9m in Terra North shares, alongside a minimum C$3.25m cumulative exploration expenditure commitment that Terra North must meet before it can exercise the option.
"This amendment secures C$560,000 of additional deemed equity consideration for Fulcrum and preserves exposure to a further C$2.125 million of potential cash and equity consideration, together with a retained 1% NSR royalty upon exercise of the option," said chief executive Ryan Mee.
News Intelligence what this means for the company
Fulcrum Metals has amended its Saskatchewan uranium option deal with Terra North Resources, converting C$560,000 of scheduled cash-and-share consideration into 5.6m Terra North shares at a C$0.10 deemed price, and deferring a further C$75,000 cash payment to the earlier of Terra North's public listing or 31 October. The shift substitutes illiquid equity in an unlisted counterparty for near-term cash, reducing Fulcrum's immediate liquidity benefit while preserving C$2.125m in future potential consideration and a 1% NSR royalty upon exercise.
The amendment trades certainty for optionality: Fulcrum foregoes C$560,000 in cash now in favour of equity exposure to Terra North's eventual listing, a bet on that company's ability to fund and execute its uranium exploration commitment (C$3.25m minimum). The deferral of the second C$75,000 payment adds execution risk, though the October 31 backstop caps the wait. For a company that secured up to US$20m in non-dilutive financing from Chancery Royalty in June, the liquidity impact is modest against that backdrop, but the shift signals Terra North may face near-term cash constraints.
Insights assembled by AI. Editor-reviewed and grounded in tickstock’s coverage and proprietary knowledge graph.
Content is for informational purposes only, not financial advice.
